In a radical revamp of its risk
assessment process, the European Food
Safety Authority (EFSA) could publish confidential data if deemed essential to protecting public health, according to
draft rules aimed at boosting transparency and trust in science.
The
draft lacks a clear description of the criteria for eliminating an increasing number of non-GLP studies that indicate the possibility of toxic effects that are not mediated by interaction of BPA with the estrogen receptor, and the Subcommittee does not agree with the exclusion of the non-GLP studies in the
safety assessment.